International Journal of Clinical and Experimental Neurology
ISSN (Print): 2379-7789 ISSN (Online): 2379-7797 Website: http://www.sciepub.com/journal/ijcen Editor-in-chief: Zhiyou Cai, MD
Open Access
Journal Browser
Go
International Journal of Clinical and Experimental Neurology. 2017, 5(1), 18-27
DOI: 10.12691/ijcen-5-1-5
Open AccessArticle

Prevalence of Comorbidity of Migraine and Atopic Diseases among Patients with Idiopathic Epilepsy in Zagazig University Hospitals

Yosria Abd Al Hameed Altaweel1, Amal Salah El-Din Mohamed El-Motayam1, Khaled Aly El-Sharkawy1 and Mohammed Hanafy Aly Ghonemy1,

1Neurology Department, Zagazig University, Egypt

Pub. Date: November 17, 2017

Cite this paper:
Yosria Abd Al Hameed Altaweel, Amal Salah El-Din Mohamed El-Motayam, Khaled Aly El-Sharkawy and Mohammed Hanafy Aly Ghonemy. Prevalence of Comorbidity of Migraine and Atopic Diseases among Patients with Idiopathic Epilepsy in Zagazig University Hospitals. International Journal of Clinical and Experimental Neurology. 2017; 5(1):18-27. doi: 10.12691/ijcen-5-1-5

Abstract

Comorbid conditions are common in people with epilepsy, and their presence has important implications for diagnosis, treatment, medical costs and quality of life. Migraines are most common in patients with epilepsy, with a reported prevalence of 20-40%, while epidemiologic studies on the association between allergic disease and epilepsy in adults and children have found conflicting results. Objectives: The study was designed to assess the prevalence of migraine and atopic diseases: bronchial asthma(BA) and atopic eczema in patients with idiopathic epilepsy. Methods: This study included 118 patients with idiopathic generalized epilepsy(IGE), 68 male and 50 female with ages ranged from 2-20 years (mean age 9.8±5.4 years). The patient will be considered :to have migraine according to criteria of ICHD 3 (2013), to have BA according to diagnostic criteria of National Asthma Education and Prevention Program (2007) and to have atopic eczema according to Williams criteria (1994). The patients were classified into two groups, group Ι epileptic patients without comorbidity and groupΙΙ epileptic patients with comorbidity which was further classified into 2 subgroups, groupΙΙ-A epileptic patients with one comorbidity, group ΙΙ-B epileptic patients with multiple comorbidity. All patients were subjected to: clinical assessment via thorough history taking, complete general and neurological examination, EEG, MRI brain and routine laboratary investigations. The data were compared in both groups. Results: IGE was more common in male than female (55.9 % vs 44.1 %). Atopic eczema was the most frequent comorbid illness (32.2%) followed by migraine (24.6%) and BA (24.6%) while The prevalence of atopic eczema, migraine and BA and in the general population was 20%, 15% and 4%-20%, respectively. Epileptic patients with multiple comorbidities had a statistically significant older age of onset than epileptic patients one comorbidity and without comorbidities (P= 0.001). Also female sex was statistically significant higher in epileptics with comorbidities. Epileptics with migraine had female preponderence (69%). MA was more common (79.3%). Migraine onset followed epilepsy onset in 48.2%.Migraine attacks occurred mostly interictally. The bronchial asthma comorbidity in our patients was with a more prominent onset before epilepsy (76%). Mild asthma was more common in epileptics in our study and it was common postictally. Atopic eczema comorbidity in our patients was with an onset more commonly prior to that of epilepsy & it occurred in a mild form and usually interictally. Conclusion: Patients with IGE had comorbidity with atopic eczema (32.2%) migraine (24.6%) and BA (24.6%).Family history for epilepsy was more in patients with comorbidity and they need polytherapy of AEDs more than those without comorbidity.

Keywords:
ICHD 3: international classification of headache disorders 3rd edition MA: migraine with aura AEDs:antiepileptc drugs

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P (2005). Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia; 46: 470-2.
 
[2]  Wiebe S, Hesdorffer DC (2007). Epilepsy: being ill in more ways than one. Epilepsy Curr; 7: 145-148.
 
[3]  Gaitatzis A, Carroll K, Majeed A, Sander WJ (2004). The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia.; 45: 1613-1622.
 
[4]  Velioglu SK, Boz C, Ozmenoglu M. (2005). The impact of migraine on epilepsy: a prospective prognosis study. Cephalalgia 25: 528-535.
 
[5]  Ottman R, Lipton RB, Ettinger AB, et al. (2011). Comorbidities of epilepsy: Results from the epilepsy comorbidities and health (EPIC) survey. Epilepsia; 52: 308-315.
 
[6]  IBM Corp. released 2013. IBM SPSS statistics for windows, version 22.0 Armonk, NY: IBM Corp.
 
[7]  Srinivas HV, Shah U. (2017). Comorbidities of epilepsy. neuroindia; 65(7): 18-24.
 
[8]  Keezer MR, Sisodiya SM and Sander JW. (2016). Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol; 15: 106-15.
 
[9]  Diener HC, Charles A, Goadsby PJ, Holle D (2015). New therapeutic approaches for the prevention and treatment of migraine. The Lancet Neurology; 14 (10): 1010-22.
 
[10]  Ottman R, Lipton RB. (1994). Comorbidity of migraine and epilepsy. Neurology 44(11): 2105-2110.
 
[11]  Syvertsen M, Helde G, Stovner LJ, Brodtkorb E. (2007). Headaches add to the burden of epilepsy. J Headache Pain 8(4): 224-230.
 
[12]  Shyam Babu C, Satishchandra P, Sinha S, Subbakrishna DK. (2009). Comorbidities in people living with epilepsy. Hospital based case-control study from a resource poor setting Epilepsy Res; 80: 146-52.
 
[13]  Kelley SA, Hartman AL, Kossof EH. (2012). Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology; 79(5): 468-73.
 
[14]  Winawer MR, Connors R, Investigators EPGP. (2013). Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia 54(2): 288-295.
 
[15]  Mainieri G, Cevoli S, Giannini G, Zummo L, Letal C, Broli M, Ferri L, Santucci M, Posar A, Avoni P, Cortelli P, Tinuper P, Bisulli F. (2015). Headache in epilepsy: prevalence and clinical features. The Journal of Headache and Pain; 16: 72.
 
[16]  Elmassry HA, Nagy N, Samy N, Eid M. (2015). Cross section comparative study for comorbid migraine and major depression in epileptic patients: demographic , clinical, electroencephalography and therapeutic implications. Neuropsychatric Electrophysiology; 1: 8.
 
[17]  Weatherburn CJ, Health CA, Mercer SW, Guthrie B. (2017). Physical and mental health comorbidities of epilepsy: population-based cross-sectional analysis of 1.5 million people in scotland. Seizure; 45: 125-131.
 
[18]  To T, Stanojevic S, Moores G (2012). Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health; 12: 12-24.
 
[19]  Kobau R, Zahran H, Thurman DJ, et al, and the Centers for Disease Control and Prevention (CDC). (2008). Epilepsy surveillance among adults—19 states, behavioral risk factor surveillance system, 2005. MMWR Surveill Summ; 57: 1-20.
 
[20]  Elliott JO, Lu B, Shneker B, Charyton C, Layne Moore J. (2009). Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy Behav; 14: 125-29.
 
[21]  Russ SA, Larson K, Halfon N. (2012). A national profile of childhood epilepsy and seizure disorder. Pediatric; 129: 256-64.
 
[22]  Kadima N, Kobau R, Zack M, Helmers S, and the Centers for Disease Control and Prevention (CDC). (2013). Comorbidity in adults with epilepsy—United States, 2010. MMWR Morb Mortal Wkly Rep; 62: 849-53.
 
[23]  Williams HC (2005). Clinical practice. Atopic dermatitis. N Engl J Med; 352(22): 2314-24.
 
[24]  Frediani T, Lucarelli1 S, Pelliccia A, Vagnucci B, Cerminara C, M. Barbato M, Cardi E. (2001). Allergy and childhood epilepsy: a close relationship?. Acta Neurol Scand; 104: 349-352.
 
[25]  Silverberg JI, Joks R, Durkin HG. (2014). Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy; 69: 95-103.
 
[26]  Strom M and Silverberg J. (2016). Allergic disease is associated with childhood seizures: An analysis of the 1997-2013 National Health Interview Survey. J Allergy Clin Immunol ; 137(3): 951-3.
 
[27]  Silverberg JI. (2017). Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol; 35(4): 360-366.
 
[28]  Yamane LE, M.A. Montenegro MA, Guerreiro MM. (2004). Comorbidity headache and epilepsy in childhood. Neuropediatrics; 35: 99-102.
 
[29]  Schon F, Blau JN. (1987). Post-epileptic headache and migraine. J Neurol Neurosurg Psychiatry 50(9): 1148-1152.
 
[30]  Tonini MC, Giordano L, Atzeni L, Bogliun G, Perri G, Saracco MG, Tombini M, Torelli P, Turazzini M, Vernieri F, Aguggia M, Bussone G, Beghi E, EPICEF Group. (2012). Primary headache and epilepsy: a multicenter cross-sectional study. Epilepsy Behav 23(3): 342-347.
 
[31]  Nahid A and Hakimeh J. (2015). The Prevalence of Migraine and Tension Type Headaches among Epileptic Patients. Caspian J Neurol Sci; 1(3): 41-46.
 
[32]  Ludvigsson P, Hesdorffer D, Olafsson E, et al. (2006). Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol; 59: 210-3.
 
[33]  Toldo I, Perissinotto E, Menegazzo F, et al. (2010). Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain; 11: 235-240.
 
[34]  Bilan N, Ghaffari S (2008). Association of asthma and epilepsy. Rsearch Journal of Biological Sciences; 3(12): 1370-1372.
 
[35]  Czubkowska I, Karkowska B, Najberg E, Zychowicz C and Nowacka K. (1994). Epilepsy as a complication of bronchial asthma. Pol Tyg Lek; 49(18): 448-50.
 
[36]  El-Taweel YA, Moustafa AA, Hisham MA. (1999). Neurological manifestations in children with bronchial asthma. The Gaz Egypt Ped; 47-3.
 
[37]  Chen MH, Wu YH, Su TP, Chen YS, Hsu JW, Huang KL, Li CT, Lin WC, Chang WH, Chen TJ, Bai YM. (2014). Risk of epilepsy among patietns with atopic dermatitis: A nationwide longitudinal study. Epilepsia; 55(8): 1307-12.
 
[38]  El-Senousey MY, El-Heneedy YA, Ghali AA, Bahnas WS. (2011). Relationship between Primary Headache and Epilepsy in Children and Adolescents. Egypt J Neurol Psychiat Neurosurg; 48(3): 223-228.
 
[39]  Gaitatzis A, Sisodiya SM, Sander JW. (2012). The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia; 53: 1282-93.
 
[40]  Hesdorffer DC, Ludvigsson P, Hauser WA, Olafsson E, Kjartansson O. (2007). Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure. Epilepsy Res 75: 220-223.
 
[41]  Kanner AM. (2016). Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol; 12(2): 106-16.